Sponsor:
Vanderbilt University Medical Center
Code:
NCT03704207
Conditions
Primary Ciliary Dyskinesia
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Not accepted
Interventions
nNO testing
Brief summary:
Conditions
Primary Ciliary Dyskinesia
Study ID
NCT03704207
Start date
Jun 1, 2017
Status verified date
Jun, 2026
Completion date
Jun 1, 2028
Anticipated
Primary completion date
Jun 1, 2028
Anticipated
Eligibility Criteria
Sex: All
Age: 1+
Healthy Volunteers: Not accepted
Enrollment
200 participants
Anticipated
Intervention Model
Single group
Primary purpose
Diagnostic
Arms
other: Nasal Nitric Oxide testing and collection of clinical data
Interventions
nNO testing
Primary outcome measure
Central contacts
Locations
Vanderbilt Children's hospital
Recruiting
Nashville, Tennessee, United States, 37232
Sponsor
Vanderbilt University Medical Center
Last update posted
Jul 6, 2026
Last verified
Jun, 2026
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Vanderbilt University Medical Center on 2026-07-06.